Posted 12/18/2023, 3:30:00 PM
Tissue Engineering Market Poised for Robust 15% CAGR Growth to $8.9B by 2028, Driven by 3D Bioprinting and Scaffold Demand
- Tissue engineering market valued at $4.4 billion in 2023, expected to reach $8.9 billion by 2028 at a 15.3% CAGR
- Growth driven by demand for innovative tissue engineering solutions and 3D bioprinting advancements
- Scaffolds product type accounted for largest market share in 2022
- North America accounted for largest regional market share in 2022
- Key players include Organogenesis, AbbVie, Baxter, BD, B. Braun, TEIJIN Limited, and others